Clinical Trial Update: Botulinum Toxin-A for Hidradenitis Suppurativa [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial of botulinum toxin A for hidradenitis suppurativa has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hidradenitis Suppurativa

Drugs mentioned

• Botulinum toxin A (botulinum toxin type A)

Snippet

Sponsor: Yale University | Conditions: Hidradenitis Suppurativa, Hidradenitis Suppurativa \(HS\) | Phase 4 | Status: WITHDRAWN